Bookmark

Add to MyYahoo RSS

Merck News

News on Merck (Ticker: MRK) continually updated from thousands of sources around the net.

18 hrs ago | Seeking Alpha

Gilead: Let's Make A Deal

The HCV franchise has transformed Gilead in the past two years from a solid mid-tier biopharma company into a pharma giant with a market cap rivaling Merck and Pfizer.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Merck & Co., Bain & Company, Vaccine Company, Pfizer

23 hrs ago | Forbes.com

Dow Analyst Moves: MRK

Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry

Yesterday | The Motley Fool

3 Reasons Merck & Co., Inc.'s Stock Could Fall

Unfortunately, timing the stock market is practically impossible to do, and as you can see below, long-term shareholders in Merck haven't been rewarded on a nominal basis for hanging on to their shares.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co., Healthcare Law, Law, Food and Drug Administration, Financial Markets

Wed Aug 27, 2014

GlobeNewswire

Ablynx Announces Half-Year Results for 2014

Ablynx [Euronext Brussels: ABLX] today announced its results for the six-month period ending 30 June 2014, which have been prepared in accordance with the IAS 34 "Interim Financial Reporting" as adopted by the European Union.

Comment?

Related Topix: Biotech, Healthcare Industry

GlobeNewswire

Durata Therapeutics Names Wendy Yarno and J. Martin Carroll to Its Board of Directors

Durata Therapeutics today announced that Wendy Yarno and Marty Carroll were added to its Board of Directors at a quarterly meeting of the Board held today.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Women's Health, Health

AmericanBankingNews.com

Merck & Co. Coverage Initiated by Analysts at Deutsche Bank

The firm set a "hold" rating on the stock. A number of other firms have also recently commented on MRK.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co.

BioSpace

Novira Therapeutics Announces Appointment Of As Chair Of Scientific Advisory Board

In this role he will also function as a Senior Advisor to the Company. , Chief Executive Officer at Novira.

Comment?

Related Topix: Hepatitis, Medicine, Biotech, Healthcare Industry, Infectious Diseases, Pharmacology

Tue Aug 26, 2014

Seeking Alpha

Veritiv Corp. For The Value Investor?

Veritiv presents opportunity for the value investor with corporate synergies and as it trades at a discount to book value.

Comment?

Related Topix: Idenix Pharmaceuticals, Biotech, Medicine, Healthcare Industry

In-PharmaTechnologist.com

EMD Millipore to supply Samsung's Yervoy plant in 10-year deal

EMD Millipore has been contracted to supply raw materials to the Samsung Biologics plant where ingredients for BM-S' anticancer monoclonal antibody Yervoy are made.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, South Korea, World News,

TheStreet.com

Why Merck (MRK) Stock Is Gaining Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mozilla, Health, Lung Cancer, Financial Markets

Reuters

UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Health, Lung Cancer, Merck & Co.

BioSpace

Drug Giants Merck & Co., Inc. And Pfizer Inc. Forge Cancer Pact

Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen Agreement to Combine Merck's Investigational Anti-PD-1 Antibody Pembrolizumab and Pfizer's Crizotinib in Clinical Trial NEW YORK & WHITEHOUSE STATION, N.J., Aug 26, 2014 -- Pfizer Inc. and Merck & Co.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Health, Lung Cancer, Oncology

Mon Aug 25, 2014

Sys-Con Media

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

This report provides elemental information and data relating to the clinical trials on Aortic Valve Stenosis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

AmericanBankingNews.com

Merck & Co. Reaches New 1-Year High at $59.87

Merck & Co. shares reached a new 52-week high on Monday , ARN reports. The company traded as high as $59.87 and last traded at $59.79, with a volume of 2,230,069 shares changing hands.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co., Startups, Bain & Company, Vaccine Company

TheStreet.com

Why Jim Cramer Thinks Merck (MRK), Pfizer (PFE), GlaxoSmithKline...

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Pfizer, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Mozilla

Reuters

Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology, Merck & Co., Food and Drug Administration, Bristol Myers Squibb, Skin Cancer, Health

Sun Aug 24, 2014

GlobeNewswire

Advaxis and Merck Form Collaboration to Evaluate Investigational...

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Merck, known as MSD outside the United States and Canada, through its subsidiaries, to evaluate the combination of Advaxis's Lm -LLO cancer immunotherapy, ADXS-PSA, with Merck's investigational ... (more)

Comment?

Related Topix: Medicine, Cancer, Health, Biotech, Healthcare Industry, Prostate Cancer, Oncology, Lung Cancer

Reuters

Advaxis, Merck to test immune therapies against prostate cancer

Advaxis Inc on Monday said it will test an experimental immuno-oncology drug in combination with a high-profile immunotherapy from Merck & Co Inc as a treatment for patients with advanced prostate cancer.

Comment?

Related Topix: Biotech, Prostate Cancer, Medicine, Healthcare Industry, Oncology, Skin Cancer

Fri Aug 22, 2014

SchaeffersResearch.com

Dow Jones Industrial Average Dips as Russia Spooks the Street

The Dow Jones Industrial Average spent most of the session modestly south of breakeven, save a brief period of post-Yellen upside.

Comment?

Related Topix: Merck & Co., Biotech, Medicine, Healthcare Industry, Startups, Cisco Systems, Opinion, Day Trading, Financial Markets, Personal Finance

Thu Aug 21, 2014

Centers for Disease Control and Preve...

Closure of Varicella-Zoster Virus-Containing Vaccines Pregnancy ...

Vaccines that contain live attenuated varicella-zoster virus are contraindicated during pregnancy .

Comment?

Related Topix: Chickenpox, Health, Biotech, Medicine, Healthcare Industry, Merck & Co., Vaccinations, Centers for Disease Control and Prevention

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••